Yutong Zhang
Yutong obtained his undergraduate and master’s degree in chemistry from Imperial College London (2012-2016). His master’s project on Drug Discovery and Development was focused on Developing SIRT2 inhibitors as a novel strategy in Parkinson’s disease under the supervision of Dr Matthew Fuchter. Yutong joined the Brown group as a PhD student in 2016, he is currently investigating novel ligands for applications in protein recognition via SELEX and related processes.